Related Experiment Video
Updated: Jan 3, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Identifying Patients With Inflammatory Bowel Diseases in an Administrative Health Claims Database: Do Algorithms
Yizhou Ye1, Sudhakar Manne1, Dimitri Bennett1,2
1Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.
Insights
Different algorithms identify varying numbers of inflammatory bowel disease patients in health claims data. This highlights the critical need for algorithm validation to ensure accurate patient identification and disease classification.
Area of Science:
- Health Informatics
- Gastroenterology
- Epidemiology
Background:
- Administrative health claims databases are utilized for patient and disease outcome detection.
- Accurate identification of inflammatory bowel disease (IBD) patients is crucial for research and clinical management.
Purpose of the Study:
- To compare the performance of different algorithms in identifying patients with inflammatory bowel disease (IBD) classifications using a single administrative claims database.
- To assess the variability in patient cohort sizes and disease proportions based on algorithm selection.
Main Methods:
- A literature review identified algorithms for defining IBD, ulcerative colitis, Crohn's disease, and IBD unspecified in claims databases.
- Three selected algorithms (A, B, and C) were applied to the Optum Clinformatics® Data Mart database (June 2000–March 2017).
- Patient cohorts identified by each algorithm were compared for size and disease classification distribution.
Main Results:
- Algorithms identified significantly different numbers of total IBD patients (323,833; 246,953; 171,537).
- Proportions varied: ulcerative colitis (32.0%–47.5%), Crohn's disease (38.6%–43.8%), and IBD unspecified (8.7%–26.6%).
- Only 5.1% of IBD unspecified patients were identified by all three algorithms; Algorithm C identified the smallest cohorts for most categories.
Conclusions:
- This study is the first to compare IBD patient identification across multiple algorithms within a single claims database.
- Significant discrepancies in patient identification and classification underscore the need for algorithm validation.
- Validated algorithms are essential for accurate epidemiological studies and resource allocation in IBD research.
Abstract:
Application of selective algorithms to administrative health claims databases allows detection of specific patients and disease or treatment outcomes. This study identified and applied different algorithms to a single data set to compare the numbers of patients with different inflammatory bowel disease classifications identified by each algorithm. A literature review was performed to identify algorithms developed to define inflammatory bowel disease patients, including ulcerative colitis, Crohn's disease, and inflammatory bowel disease unspecified in routinely collected administrative claims databases. Based on the study population, validation methods, and results, selected algorithms were applied to the Optum Clinformatics® Data Mart database from June 2000 to March 2017. The patient cohorts identified by each algorithm were compared. Three different algorithms were identified from literature review and selected for comparison (A, B, and C). Each identified different numbers of patients with any form of inflammatory bowel disease (323 833; 246 953, and 171 537 patients, respectively). The proportions of patients with ulcerative colitis, Crohn's disease, and inflammatory bowel disease unspecified were 32.0% to 47.5%, 38.6% to 43.8%, and 8.7% to 26.6% of the total population with inflammatory bowel disease, respectively, depending on the algorithm applied. Only 5.1% of patients with inflammatory bowel disease unspecified were identified by all 3 algorithms. Algorithm C identified the smallest cohort for each disease category except inflammatory bowel disease unspecified. This study is the first to compare numbers of inflammatory bowel disease patients identified by different algorithms from a single database. The differences between results highlight the need for validation of algorithms to accurately identify inflammatory bowel disease patients.
More Related Videos
09:11Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
Published on: February 14, 2021
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD: